Will Ozempic bankrupt the U.S. healthcare system?

Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate in a recent study.

Related Keywords

Vermont ,United States ,Boston ,Massachusetts ,Houston ,Texas ,Denmark ,Germany ,United Kingdom ,Danish ,Americans ,Lauren Eberly ,Brad Wenstrupr Ohio ,Bernie Sanders ,John Cawley ,Eli Lilly ,Caroline Apovian ,Phillip Swagel ,Eli Lilly Mounjaro ,Lawrence Gostin ,Donna Cooper ,Davidj Phillip ,Georgetown University ,Novo Nordisk ,Drug Administration ,Human Services ,Pensions Committee ,Senate Health ,Yale School Of Medicine ,Medicaid Services ,University Of Pennsylvania ,Sander Senate ,Centers For Medicare ,Congressional Budget Office ,Us Department Of Health ,New England Journal ,Melissa Barber ,Yale School ,Brad Wenstrup ,Reduce Obesity Act ,Weight Management ,Inflation Reduction Act ,